Sangamo Therapeutics, Inc. (SGMO) financial statements (2023 and earlier)

Company profile

Business Address 7000 MARINA BLVD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments377641362400243143209
Cash and cash equivalents17913180140502269
Short-term investments198510282260193120140
Receivables66385453
Prepaid expense     21
Other undisclosed current assets1612552  
Total current assets:399660405411248150213
Noncurrent Assets
Operating lease, right-of-use asset7371 
Property, plant and equipment524130793173
Long-term investments and receivables885122 1  
Long-term investments885122 1  
Intangible assets, net (including goodwill), including:931019295222
Goodwill4043394022 
Intangible assets, net (excluding goodwill)54585355   
Other undisclosed intangible assets, net (including goodwill)      2
Restricted cash and investments2224   
Other noncurrent assets151493500
Other undisclosed noncurrent assets  77    
Total noncurrent assets:3232792321803885
TOTAL ASSETS:722939638590287158217
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:425218211168
Accounts payable101373034
Accrued liabilities121912100
Employee-related liabilities2121 9533
Other undisclosed accounts payable and accrued liabilities  107411
Deferred revenue8692 
Deferred revenue and credits2849
Contract with customer, liability3948
Other undisclosed current liabilities  149533
Total current liabilities:1281447079451320
Noncurrent Liabilities
Long-term debt and lease obligation4438     
Operating lease, liability4438 
Liabilities, other than long-term debt175259941172945
Deferred revenue and credits2945
Deferred revenue167245 
Contract with customer, liability81108
Deferred tax liabilities, net77   
Deferred income tax liabilities77 
Other liabilities1762   
Other undisclosed noncurrent liabilities  4128254 
Total noncurrent liabilities:2192981351455485
Total liabilities:347441205223992225
Stockholders' equity
Stockholders' equity attributable to parent375498433367188136192
Common stock1111111
Additional paid in capital1,3341,2691,091930683576561
Accumulated other comprehensive income (loss)(4)5(2)(1)(0)0 
Accumulated deficit(956)(778)(657)(563)(495)(441)(369)
Stockholders' equity attributable to noncontrolling interest (1)01   
Total stockholders' equity:375497433367188136192
TOTAL LIABILITIES AND EQUITY:722939638590287158217

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues11111810284371940
Gross profit:11111810284371940
Operating expenses(294)(248)(208)(162)(93)(92)(86)
Operating loss:(183)(130)(105)(77)(56)(73)(47)
Nonoperating income
(Other Nonoperating income)
     10
Loss from continuing operations before equity method investments, income taxes:(183)(130)(105)(77)(56)(72)(46)
Other undisclosed income from continuing operations before income taxes591082  
Loss from continuing operations before income taxes:(178)(121)(95)(69)(55)(72)(46)
Income tax expense (benefit)(0)(0)   06
Net loss:(178)(121)(95)(69)(55)(72)(41)
Net income attributable to noncontrolling interest0001   
Net loss available to common stockholders, diluted:(178)(121)(95)(68)(55)(72)(41)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(178)(121)(95)(69)(55)(72)(41)
Other comprehensive income (loss)(8)8(2)(1)   
Other undisclosed comprehensive income (loss)(1)(0)1(0)   
Comprehensive loss:(188)(113)(96)(70)(55)(72)(41)
Comprehensive income, net of tax, attributable to noncontrolling interest0001   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (0)00
Comprehensive loss, net of tax, attributable to parent:(188)(113)(96)(69)(55)(72)(41)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: